MCM
PFE icon

Mattern Capital Management’s Pfizer PFE Stock Holding History

Mattern Capital Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-4,162
Closed -$213K – 125
2022
Q4 		$213K Buy
+4,162
New +$200K 0.04% 118
2022
Q3 		– Sell
-4,225
Closed -$222K – 119
2022
Q2 		$222K Sell
4,225
-85
-2% -$4.33K 0.04% 115
2022
Q1 		$223K Hold
4,310
– – 0.04% 116
2021
Q4 		$255K Buy
+4,310
New +$214K 0.04% 108

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mattern Capital Management's PFE Position: Q1 2023 in Review

Mattern Capital Management sold out of Pfizer (PFE) in Q1 2023, closing a stake of 4,162 shares — an estimated $213K sold.

Mattern Capital Management first reported a position in PFE in Q4 2021 and held it in 4 quarters. The position peaked at $255K in Q4 2021. 3,102 funds tracked by Wall St. Rank hold PFE as of Q1 2023.

  • Mattern Capital Management reported no remaining Pfizer position as of Q1 2023 after selling out during the quarter.
  • Mattern Capital Management sold 4,162 Pfizer shares in Q1 2023, an estimated $213K.
  • Mattern Capital Management first reported a position in Pfizer in Q4 2021 and held it in 4 quarters.
  • Mattern Capital Management's Pfizer position peaked at $255K in Q4 2021.
  • 3,102 funds tracked by Wall St. Rank held Pfizer as of Q1 2023.

Based on Mattern Capital Management's 13F filing for Q1 2023, filed 12 May 2023.